青年肺癌的临床特点及X线诊断

目的 阐述青年人肺癌的临床表现特点,探讨青年人肺癌的X线特征,明确其诊断的重要性。方法系统回顾了53例青年人肺癌患者的临床特点及X线表现。其中男性29例,女性24例,年龄17岁—40岁,平均年龄为31.8岁。结果 53例青年人肺癌中,左肺24例,右肺28例,双肺同时发现者1例。中央型肺癌18例,周围型肺癌34例,细支气管肺泡癌1例。结论 青年人肺癌病因较复杂,无特征表现,早期正确诊断较为困难,对于久治不愈的炎性病变,有分叶状的块状影,应高度考虑青年人肺癌的可能,并作短期随访,要结合“痰、活、镜”三检早期作出正确诊断。     

尿路梗阻与扩张的IVP延迟摄影探讨

本文总结了100例尿路梗阻所致的病理性肾盂,肾盏扩张的病例均曾行常规IVP检查。本文目的是欲寻求不同程度肾盂积水病例的最佳摄影时间。结果所有程度较重的病例,在90分、120分、180分延时拍片中均显示了尿路扩张8例,发现尿路结石。该方法提高了造影的成功率,为临床提供了有用信息,满足了诊断的基本需要。     

正常人收缩期左侧房室平面位移的超声心动图检测

目的：利用超声心动图检测正常人左侧房室平面位移幅度。方法：被检对象为１４４ 例正常人,男７２ 例,女７２ 例。按不同年龄分为６ 组,分别为：Ⅰ组（ｎ＝ ２４ ,３～６ 岁）;Ⅱ组（ｎ＝２４ ,７～１４ 岁） ;Ⅲ组（ｎ＝２４,１５～１９ 岁） ;Ⅳ组（ｎ＝ ２４,２０～３９ 岁）;Ⅴ组（ｎ＝２４ ,４０ ～５９ 岁） 及Ⅵ组（ｎ＝ ２４ ,≥６０ 岁）。结果：①左心收缩期房室平面位移测值在Ⅰ组～Ⅴ组之间无显著性差异（ Ｐ＞０－０５）,而Ⅵ组测值较Ⅰ组～Ⅴ组的测值均低（ Ｐ＜ ０－０５）;②左心收缩期房室平面位移测值不受心率、血压、体表面积及性别的影响。结论：①左侧房室平面位移测值受年龄因素影响;②制定正常左侧房室平面位移测值可以不考虑心率、血压、体表面积及性别的影响     

谈医务人员的医德导向问题

随着历史的变革,人们的道德取向发生了变化。面对商品经济大潮的冲击,医务工作者应树立什么样的医德观,塑造什么样的医护形象,对此,认为一是应加强医德导向,二是增强医德意识,三是坚持医德评价,以提高遵守社会主义医德规律的自觉性     

右室舒张功能的衰老演变规律脉冲多普勒超声心动图研究

目的　检测右室舒张功能的随龄演变规律。方法　用脉冲多普勒超声心动图记录320例健康知识分子的三尖瓣血流频谱,年龄范围26～90岁。结果　右室舒张功能指标Er、EMVr、EDVr、Eir、13FFr、NPFRr、ErAr、随年龄增加分别降低,而EDTcr、Ar、Air、AFFr、随年龄增加而增加。EATcr、EAVr、在各年龄组中无变化。结论　右室的舒张功能年龄增长而减低     

计算机2000年问题对医院的影响及对策

计算机２０００年问题对医院最明显的影响是计算机系统届时交病的信息丢失,财务系统不能正常工作,网络瘫痪等。此外,由于嵌入式问题将造成医疗设备运行混乱,从而危及病人的生命和健康。医院应采取的对策是：认知计算机２０００年问题,产品清查,确定问题范围,对问题进行评估,制定应急计划,制定解决方案,具有体实施和检验验证。     

浅谈医院门诊部工作的主要特点与基本要求

翔实地阐述了门诊工作的特点：服务对象与病种的复杂性及心态的多样性;医疗质量监控缺乏系统必 ;病人就诊高峰的相对集中性;门诊诊治工作的时效性与风险性;急诊抢救工作的突发性与应性;门诊业务工作的多元性、专业性和服务保障工作的整体性;门诊部管理职能的双重性,同时提出了相应的基本要求。     

40所军队医院病种病例分型质量评价结果分析

应用病例分型质量费用监控管理软件和ＳＡＳ６．１２统计软件包,对４０所军队医院５０万份病例样本资料进行深入分析,结果显示：病例分型组合数据稳定,分析结果合理。     

Practice protocol for the examination of specimens removed from patients with carcinoma of the urinary bladder, ureter, renal pelvis, and urethra

This article details a practice protocol for the examination and reporting of specimens removed from patients with carcinoma of the urinary bladder, ureter, renal pelvis, or urethra. It was created by a multidisciplinary task force of pathologists and oncologists established by the Cancer Committee of the College of American Pathologists. Documentation for the protocol was obtained from the previously published protocol, the medical literature, personal experience, and consultation with colleagues. After creation and review by the task force, the protocol was sent to 1000 randomly selected practicing pathologists as a survey. Their comments and suggestions were addressed in the final version. The protocol was approved by the Board of Governors of the College of American Pathologists.     

Ventricular fibrillation following administration of thrombolytic treatment: The EMIP experience

Reperfusion-induced ventricular fibrillation has been dem onstratedin animal models of myocardial ischaemia, but no evidence existsfor this in humans. The European Myocar dial Infarction Projectcompared the efficacy and safety of pre-hospital thrombolytictherapy with that of hospital therapy. The objective of thisstudy was to investigate the occurrence of reperfusion-inducedventricular fibrilla tion in acute myocardial infarction patientsfollowing thrombolytic therapy. In a double-blind multicentre trial, eligible patients wererandomized to receive anistreplase at home followed by placeboin the hospital (A/P group), or placebo followed by anistreplase(P/A group). The occurrence of ventricular fibrillation, andother adverse events were recorded on specific study forms andcould be attributed to defined time intervals. The incidence of ventricular fibrillation in the A/P group wassignificantly higher following the pre-hospital injection thanin the P/A group (2.5% vs 1.6%; P=0.021); the situation wasreversed following the hospital injection (3.6% vs 5.3%; P=0.002).No relationship was found be tween this excess of ventricularfibrillation and the patients condition, with the exceptionof the site of the infarct. These results suggest the existence of reperfusion-induced ventricularfibrillation in patients developing myocardial infarction whoreceive thrombolytic treatment.